New study suggests statin therapy may modestly reduce disease activity and inflammation in people with systemic lupus erythematosus

A new study found statin use is associated with reduced disease activity and inflammation in people with systemic lupus erythematosus (SLE), particularly in patients younger than 40 years.

This post was originally published on this site